Silex Systems Limited

ASX SLX.AX

Silex Systems Limited EBITDA for the year ending June 30, 2024: USD -14.85 M

Silex Systems Limited EBITDA is USD -14.85 M for the year ending June 30, 2024, a -303.74% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Silex Systems Limited EBITDA for the year ending June 30, 2023 was USD -3.68 M, a -31.24% change year over year.
Silex Systems Limited EBITDA for the year ending June 30, 2022 was USD -2.80 M, a 32.99% change year over year.
Silex Systems Limited EBITDA for the year ending June 30, 2021 was USD -4.18 M, a 26.85% change year over year.
Silex Systems Limited EBITDA for the year ending June 30, 2020 was USD -5.72 M, a -34.33% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

ASX: SLX.AX

Silex Systems Limited

CEO	Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D.
IPO Date	Jan. 3, 1999
Location	Australia
Headquarters	Building 64
Employees	38
Sector	Industrials
Industries Petrochemicals Biotechnology Mining Semiconductors

Description

Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.

Key trends

Past 5 years